Join the club for FREE to access the whole archive and other member benefits.

John Lewis

CSO Oision Biotechnologies, co-founder of Oisin Oncology and Chair in Prostate Cancer Research at the University of Alberta

Dr. John Lewis the co-founder of Oisin Oncology and heads its cancer-fighting platform technology development and clinical research. Dr. Lewis also holds the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta. He is an Associate Professor in the Department of Oncology and chairs the Alberta Prostate Cancer Research Initiative. Dr. Lewis has also founded three Canadian biotechnology companies.

Visit website: https://www.oisinbio.com/#the-team

 john-lewis-29301614

See also: Company Oisin Biotechnologies - Drug development company focused on the senolytic technology to fight age-related diseases

Details last updated 06-Nov-2019

John Lewis News

OncoSenX targets solid tumours with senolytics

Lifespan.io (LEAF) - 22-Oct-2019

Phase 1 clinical trial starting early 2020

Read more...